XML 16 R2.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]        
Revenue $ 3,368 $ 4,094 $ 11,327 $ 12,055
Cost of revenue (3,817) (4,006) (11,580) (11,689)
Gross profit (loss) (449) 88 (253) 366
G&A (43) (37) (131) (147)
Foreign currency gain (loss) (4) (2) (47) 58
Operating profit (loss) (496) 49 (431) 277
Interest expense (11) (11) (31) (35)
Interest income 24 48 79 149
Earnings (loss) before taxes (483) 86 (383) 391
Income tax benefit (expense) (including $230 million tax benefit and $(454) million tax expense attributable to equity method earnings (loss) in 2025 Quarter and 2025 Period, respectively) 177 (61) (536) (172)
Net earnings (loss) before equity method earnings (loss) (306) 25 (919) 219
Equity method earnings (loss) (401) 0 2,418 0
Net earnings (loss) (707) 25 1,499 219
Less: Net earnings (loss) attributable to NCI (10) (29) (23) (63)
Net earnings (loss) attributable to Fluor $ (697) $ 54 $ 1,522 $ 282
Basic EPS (in dollars per share) $ (4.30) $ 0.32 $ 9.21 $ 1.65
Diluted EPS (in dollars per share) $ (4.30) $ 0.31 $ 9.13 $ 1.63